Darwin AG Rebrands to Novogenia AG to Enhance Global Presence

Munich, July 15, 2026 – In a strategic move, Darwin AG has officially rebranded itself as Novogenia AG. This change aims to align the company's identity with its core operating brand, Novogenia GmbH, which focuses on human genetics. The decision was sanctioned during the Annual General Meeting held on June 26, 2026.

The rebranding is designed to streamline the company's image and presence across international markets. Novogenia AG seeks to establish itself as a leading provider of personalized healthcare solutions. The transition supports a unified brand identity that is consistent and recognizable to customers, partners, investors, and global markets.

CEO Dr. Daniel Wallerstorfer emphasized that the renaming strengthens their corporate and market presence, without altering strategic goals or operations. The company's stock market listing and shareholder rights remain unaffected.